BioInvent International AB (BINV) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.082x

Based on the latest financial reports, BioInvent International AB (BINV) has a cash flow conversion efficiency ratio of 0.082x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr66.78 Million ≈ $7.19 Million USD) by net assets (Skr810.74 Million ≈ $87.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BINV stock market capitalisation for the company's overall valuation and market capitalisation.

BioInvent International AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how BioInvent International AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BioInvent International AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioInvent International AB ranked by their cash flow conversion efficiency. Explore how high is BioInvent International AB's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
D-Link (India) Limited
NSE:DLINKINDIA
0.090x
Flutter Entertainment PLC
LSE:FLTR
0.034x
Reconnaissance Energy Africa Ltd
V:RECO
-0.010x
FIGX Capital Acquisition Corp. Class A Ordinary Share
NASDAQ:FIGX
-0.001x
E-Life Mall Corp
TW:6281
0.110x
KT Hitel Corporation. Limited
KQ:036030
0.052x
Midsona AB (publ)
ST:MSON-B
0.016x
Indo Borax & Chemicals Limited
NSE:INDOBORAX
0.114x

Annual Cash Flow Conversion Efficiency for BioInvent International AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of BioInvent International AB from 2002 to 2024. View BioInvent International AB (BINV) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr885.82 Million
≈ $95.33 Million
Skr-380.47 Million
≈ $-40.94 Million
-0.430x -64.64%
2023-12-31 Skr1.31 Billion
≈ $140.95 Million
Skr-341.69 Million
≈ $-36.77 Million
-0.261x -916.36%
2022-12-31 Skr1.61 Billion
≈ $172.84 Million
Skr-41.23 Million
≈ $-4.44 Million
-0.026x +85.73%
2021-12-31 Skr1.37 Billion
≈ $147.11 Million
Skr-245.84 Million
≈ $-26.46 Million
-0.180x -113.52%
2020-12-31 Skr743.50 Million
≈ $80.01 Million
Skr-62.62 Million
≈ $-6.74 Million
-0.084x +88.62%
2019-12-31 Skr169.44 Million
≈ $18.23 Million
Skr-125.43 Million
≈ $-13.50 Million
-0.740x +54.13%
2018-12-31 Skr87.62 Million
≈ $9.43 Million
Skr-141.39 Million
≈ $-15.22 Million
-1.614x -176.96%
2017-12-31 Skr130.22 Million
≈ $14.01 Million
Skr-75.88 Million
≈ $-8.17 Million
-0.583x -86.35%
2016-12-31 Skr230.44 Million
≈ $24.80 Million
Skr-72.05 Million
≈ $-7.75 Million
-0.313x +87.31%
2015-12-31 Skr29.45 Million
≈ $3.17 Million
Skr-72.57 Million
≈ $-7.81 Million
-2.464x -69.91%
2014-12-31 Skr52.43 Million
≈ $5.64 Million
Skr-76.03 Million
≈ $-8.18 Million
-1.450x -30.04%
2013-12-31 Skr49.01 Million
≈ $5.27 Million
Skr-54.65 Million
≈ $-5.88 Million
-1.115x +68.83%
2012-12-31 Skr47.62 Million
≈ $5.13 Million
Skr-170.38 Million
≈ $-18.34 Million
-3.578x -790.00%
2011-12-31 Skr137.95 Million
≈ $14.85 Million
Skr-55.45 Million
≈ $-5.97 Million
-0.402x +74.66%
2010-12-31 Skr74.19 Million
≈ $7.98 Million
Skr-117.70 Million
≈ $-12.67 Million
-1.586x +30.58%
2009-12-31 Skr55.63 Million
≈ $5.99 Million
Skr-127.14 Million
≈ $-13.68 Million
-2.285x -1308.90%
2008-12-31 Skr231.30 Million
≈ $24.89 Million
Skr43.73 Million
≈ $4.71 Million
0.189x +220.57%
2007-12-31 Skr214.12 Million
≈ $23.04 Million
Skr12.63 Million
≈ $1.36 Million
0.059x +106.42%
2006-12-31 Skr110.15 Million
≈ $11.85 Million
Skr-101.23 Million
≈ $-10.89 Million
-0.919x -90.80%
2005-12-31 Skr219.00 Million
≈ $23.57 Million
Skr-105.48 Million
≈ $-11.35 Million
-0.482x -15.43%
2004-12-31 Skr212.68 Million
≈ $22.89 Million
Skr-88.74 Million
≈ $-9.55 Million
-0.417x -92.09%
2003-12-31 Skr304.96 Million
≈ $32.82 Million
Skr-66.25 Million
≈ $-7.13 Million
-0.217x -710.31%
2002-12-31 Skr394.25 Million
≈ $42.43 Million
Skr-10.57 Million
≈ $-1.14 Million
-0.027x --

About BioInvent International AB

ST:BINV Sweden Biotechnology
Market Cap
$160.04 Million
Skr1.49 Billion SEK
Market Cap Rank
#17457 Global
#290 in Sweden
Share Price
Skr22.60
Change (1 day)
+1.12%
52-Week Range
Skr21.25 - Skr33.90
All Time High
Skr95.26
About

BioInvent International AB (publ), a clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. The company's drug candidates include BI-1808, an anti- tumor necrosis factor receptor-2 (TNFR2) antibody in Phase 2a trial for the treatment of solid tumors and a type of blood cancer; BI-1206, an a… Read more